Ethris: ETH47ForPrevention Of Respiratory Viral Illnesses In Asthmatics Shows Promising Preliminary Phase 1 Results
ETH47, a nasally administered mRNA drug candidate was safe,well-tolerated by healthy participants, and did not result in any clinically relevant ...
![Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]](https://www.2minutemedicine.com/wp-content/uploads/2013/08/ca68dc0329bef0b42ccae7b6656a0f_gallery-350x250.jpg)




